Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG.
Mori, G., Chiarelli, L.R., Esposito, M., Makarov, V., Bellinzoni, M., Hartkoorn, R.C., Degiacomi, G., Boldrin, F., Ekins, S., de Jesus Lopes Ribeiro, A.L., Marino, L.B., Centarova, I., Svetlikova, Z., Blasko, J., Kazakova, E., Lepioshkin, A., Barilone, N., Zanoni, G., Porta, A., Fondi, M., Fani, R., Baulard, A.R., Mikusova, K., Alzari, P.M., Manganelli, R., de Carvalho, L.P., Riccardi, G., Cole, S.T., Pasca, M.R.(2015) Chem Biol 22: 917-927
- PubMed: 26097035 
- DOI: https://doi.org/10.1016/j.chembiol.2015.05.016
- Primary Citation of Related Structures:  
4ZDI, 4ZDJ, 4ZDK - PubMed Abstract: 
To combat the emergence of drug-resistant strains of Mycobacterium tuberculosis, new antitubercular agents and novel drug targets are needed. Phenotypic screening of a library of 594 hit compounds uncovered two leads that were active against M. tuberculosis in its replicating, non-replicating, and intracellular states: compounds 7947882 (5-methyl-N-(4-nitrophenyl)thiophene-2-carboxamide) and 7904688 (3-phenyl-N-[(4-piperidin-1-ylphenyl)carbamothioyl]propanamide) ...